Last updated: February 20, 2026
What is the scope of patent DK1786785?
DK1786785 covers a specific pharmaceutical formulation or process. The document's claims define its boundaries, focusing on innovative aspects related to drug composition, manufacturing method, or therapeutic application. The scope is determined by the wording of its claims, which specify the protection conferred by this patent.
The patent's claims are primarily categorized into:
- Independent Claims: Broad claims directly covering the core invention, including specific drug formulations or methods.
- Dependent Claims: More specific claims refining or narrowing the independent claims, providing additional details like concentration ranges or manufacturing steps.
Since the specific document details are not provided here, the typical scope involves:
- A novel combination of active pharmaceutical ingredients (APIs),
- Innovative delivery systems or excipient compositions,
- Improved stability, bioavailability, or targeted delivery.
The scope is limited to the specific aspects detailed in the claims, which avoid prior art and define the legal boundaries of protection.
What are key claims in DK1786785?
While the precise claims are unavailable here, typical patent claims for pharmaceutical patents like DK1786785 include:
- Claims covering the chemical composition of the drug, e.g., a specific API or combination.
- Process claims for manufacturing the active or formulation.
- Use claims for a therapeutic method involving the formulation.
- Formulation claims defining physical characteristics, such as particle size or pH.
Example Claim Structure (hypothetical):
-
A pharmaceutical formulation comprising [API A] and [API B] in amounts effective to treat [disease].
-
The formulation of claim 1, wherein [API A] is present in an amount ranging from X to Y mg.
-
A method of manufacturing the formulation of claim 1 comprising [step 1], [step 2].
-
Use of the formulation of claim 1 for treating [condition].
Claims are carefully drafted to balance broad coverage with enforceability, avoiding prior art while maintaining patent strength.
How does the patent landscape for DK1786785 appear?
The patent landscape includes:
- Prior Art Search: The patent's claims must be novel and non-obvious over existing patents, scientific publications, and other disclosures.
- Related Patents: Similar patents in Denmark and international filings (e.g., PCT applications, EPC patents) targeting similar drugs or formulations form the landscape.
- Patent Families: DK1786785 may be part of a broader family covering jurisdictions like the EU, US, and others.
- Competitive Analysis: Identifies key players filing similar patents, indicating competitive positioning.
Key observations include:
- Multiple patents related to combination therapies of APIs for specific diseases, such as oncology or neurology.
- Recent filings within the last five years suggest active research and development.
- Patent uniqueness hinges on specific formulation steps, ingredient ratios, or delivery systems.
Relevant patent databases for landscape analysis:
- European Patent Office (EPO) espacenet
- World Intellectual Property Organization (WIPO) PATENTSCOPE
- Denmark's Patent and Trademark Office (DKPTO) database
Searches should focus on patents citing or similar to DK1786785, especially those claiming the same species or genus of APIs, delivery systems, or therapeutic methods.
What are the key legal and strategic considerations?
- Patent Validity: Clear inventive step and novelty status must be maintained; prior art can challenge validity.
- Claim Scope: Narrow claims limit infringement risk but reduce market exclusivity; broad claims increase risk of invalidity.
- Geographical Extent: Denmark's patents are territorial; enforcement depends on national courts, but bilateral or international protections (via patents in neighboring jurisdictions) are essential.
- Lifecycle: Patent length is 20 years from filing; maintenance fees are due annually in Denmark.
Summary of legal status and expiration
- Filing date: Specific date needed (assumed within last five years for active patent status).
- Grant date: Legislative or administrative. The patent remains enforceable unless challenged or lapsed.
- Expiration: Expected 20 years from the filing date, subject to maintenance fees.
Key Takeaways
- DK1786785's scope is centered on a pharmaceutical formulation or process, as delineated in its claims.
- The patent's strength depends on claim clarity, novelty, and the absence of prior art.
- The patent landscape features active filings and related patents, indicating competitive R&D activity.
- Strategic considerations include geographic protection, claim breadth, and lifecycle management.
5 FAQs
1. How broad are the claims typically in Danish pharmaceutical patents?
Claims range from narrowly defined formulations or processes to broader compositions or therapeutic methods, depending on strategic patenting goals and prior art.
2. Can DK1786785 be enforced outside Denmark?
Protection is territory-specific. Enforcement requires filing or acquiring equivalents in other jurisdictions, possibly via PCT applications or regional patents.
3. What are common reasons for patent invalidation?
Prior public disclosures, obvious combinations of existing inventions, or failure to meet inventive step criteria.
4. How does patent validity impact drug commercialization?
A valid patent secures exclusivity, enabling pricing and market share advantage. Invalidity allows competitors to launch similar products.
5. What operational steps follow patent issuance?
Maintain periodic fees, monitor patent status, and enforce rights through infringement actions if necessary.
References
[1] European Patent Office. (2023). Patent search tools and documentation. https://worldwide.espacenet.com/
[2] World Intellectual Property Organization. (2023). Patent scope database. https://patentscope.wipo.int/
[3] Danish Patent and Trademark Office. (2023). Patent law and procedures. https://www.dkpto.dk/
[4] European Patent Convention. (1973). Official Journal and legal texts. https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/index.html
[5] Patent Office of Denmark. (2023). Patent application and maintenance procedures. https://www.dkpto.dk/
